Two-fold regional variation in initiation of anti-osteoporosis medication after hip fracture in the UK
Objective: Describe UK regional variation in prescription of anti-osteoporosis drug therapy before and after a primary hip fracture during 1999–2013.
| Hlavní autoři: | , , , , , , , |
|---|---|
| Médium: | Conference item |
| Vydáno: |
Springer Verlag
2016
|
| Shrnutí: | Objective: Describe UK regional variation in prescription of anti-osteoporosis drug therapy before and after a primary hip fracture during 1999–2013. |
|---|